Read-only by design — Olmem never buys, sells, shorts, or places any order. This platform provides market research and decision-support tools only. It does not provide personalized financial advice, does not guarantee investment results, and does not execute trades. All investment decisions are the responsibility of the user.
O
← Scanner

ABOSAcumen Pharmaceuticals, Inc. Common Stock

Unknown·Unknown·NASDAQ·Mkt cap $0.00
$2.91
-$0.13 (-4.28%) today
IEX feed · not consolidated
Last updated Aug 31, 1:00 PM
66/100 Opportunity
55Risk
86Momentum
77Pullback
72Quality
50Valuation
91Trend
Price & History (up to 5 years)
→
Low 0.00— support · — resistanceHigh 0.00
Technical Indicators
RSI (14)54.9
MACD hist0.03
ATR (14)0.18
SMA 202.48
SMA 502.43
SMA 2002.32
Rel volume0.7x
Boll upper2.85
Boll lower2.11
52w high3.60
52w low1.19
5y high20.29
5y low0.86
Hist. vol85%
Max drawdown-36%
Long-Term UptrendStrong Momentum WatchPossible Dip BuyEntry: Pullback Watch
Decision SummaryInternal Rule-Based Analysis
Current Rating
Neutral / Needs Confirmation
Opportunity Score
66/100
Risk Level
Moderate
Best Action
Add to watchlist and monitor for confirmation

Why: ABOS is trading near recent levels (-2.6% today). Overall, the company is reasonably solid. The long-term trend remains up. Price is holding above key moving averages with constructive structure. This may be worth monitoring, but confirmation is needed before acting.

What to watch: Volume confirmation, hold of nearest support, next earnings date, sector strength, and news sentiment.

Avoid if: Price breaks below support on heavy volume or company guidance weakens.

Internal Rule-Based Analysis · Learning From Historical Outcomes. This rating comes from Olmem’s internal scoring and historical pattern tracking. It is not a guaranteed prediction.

Research only — not financial advice. Olmem never executes trades.

All Scores
Company Quality72
Historical Context50
Valuation50
Trend91
Momentum86
Pullback77
News Sentiment50
Business Move50
Sector Strength59
Risk/Reward43
Entry Timing55
Sell Risk30
Risk55

News & business-move scores come from Olmem’s rule-based news engine (keyword-classified headlines) — no AI. They default to a neutral 50 when there is no recent news.

Recent NewsLive headlines

Real headlines from across the web. By default Olmem reads them with its rule-based news engine (keyword-classified — no AI) to set the News Sentiment score. Connect your own AI provider to have it read these actual headlines in the AI Stock Explanation.